Login
$CBLO
$20.09 +$20.06 (61713.54%) Close

Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2025
As of Mar 31, 2026
Q2 FY2025
As of Dec 31, 2025
Q1 FY2025
As of Sep 30, 2025
Q4 FY2024
As of Jun 30, 2025
Q3 FY2024
As of Mar 31, 2025
Q2 FY2024
As of Dec 31, 2024
Q1 FY2024
As of Sep 30, 2024
Q4 FY2023
As of Jun 30, 2024
Q3 FY2023
As of Mar 31, 2024
Q2 FY2023
As of Dec 31, 2023
Q1 FY2023
As of Sep 30, 2023
Q4 FY2022
As of Jun 30, 2023
Q3 FY2022
As of Mar 31, 2023
Q2 FY2022
As of Dec 31, 2022
Q1 FY2022
As of Sep 30, 2022
Q4 FY2021
As of Jun 30, 2022
Q3 FY2021
As of Mar 31, 2022
Q2 FY2021
As of Dec 31, 2021
Q1 FY2021
As of Sep 30, 2021
Cash and cash equivalents
Cryptocurrency
Inventory
Prepaid Expenses
Total Current Assets
Intangible assets - cryptocurrency
TOTAL ASSETS
       Accrued liabilities
       Loan to Company - related party
       Loan - company vehicle
       Loan to company
       Loan to company – related party
       Convertible loans, net of discount
       Derivative Liability
TOTAL LIABILITIES
Preferred stock ($0.001 par value, 20,000,000 shares authorized; 5,000,000 designated as Series A Convertible Preferred Stock (“Series A”) with 4,500,000 and 0 shares of Series A issued and outstanding as of March 31, 2026, and June 30, 2025, respectively)
Common stock ($0.001 par value, 1,500,000,000 shares authorized, 465,935,905 and 274,736,005 shares issued and outstanding as of March 31, 2026, and June 30, 2025, respectively)
Additional paid-in capital
Shares payable
Accumulated deficit
Accumulated other comprehensive income
Total Stockholders’ Equity (Deficit)
TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY (DEFICIT)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support